Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Lilly Head Lechleiter Streamlines Operations

This article was originally published in The Pink Sheet Daily

Executive Summary

Exec, who assumed CEO role April 1, takes steps to eliminate "bureaucracy" in U.S., R&D units.

You may also be interested in...



Lilly CEO Taurel Passes Baton To Lechleiter Effective April 1

As president and chief operating officer since October 2005, Lechleiter has been groomed for the post.

Lilly Aims To Have 30 NMEs In Clinic By 2009

Goal is to launch an average of two products per year by 2011 and three a year starting in 2014, CEO Taurel says.

Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel